We are live on
!
Find out more
TG Therapeutics
TGTX
TGTX
363 hedge funds and large institutions have $3.5B invested in TG Therapeutics in 2026 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 136 increasing their positions, 105 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
42% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 48
30% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 105
14% more capital invested
Capital invested by funds: $3.08B → $3.5B (+$424M)
3% more funds holding
Funds holding: 351 → 363 (+12)
1.02% more ownership
Funds ownership: 64.98% → 65.99% (+1%)
0% more call options, than puts
Call options by funds: $82.4M | Put options by funds: $82.3M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
363
Holders Change
+12
Holders Change %
+3.42%
% of All Funds
4.47%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
68
Increased
136
Reduced
105
Closed
48
Calls
$82.4M
Puts
$82.3M
Net Calls
+$53K
Net Calls Change
+$13M
Top Buyers
| 1 |
Jane Street
New York
|
+$31.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$27.2M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$26.5M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$21.3M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$18.2M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$26.5M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$21.4M |
| 3 |
Man Group
London,
United Kingdom
|
-$17.9M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$16.7M |
| 5 |
Millennium Management
New York
|
-$16.5M |
